Richard D. Pilnik, Director at DiaMedica Therapeutics Inc. (DMAC), bought 6,250 shares at $4.00 ($25K) on 2018-12-11, disclosed to the SEC on 2018-12-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| DMAC | BUY | 2021-08-17 | $49K | — | Filing → |
| DMAC | BUY | 2020-12-04 | $54K | — | Filing → |
| DMAC | BUY | 2019-08-19 | $20K | — | Filing → |